Cough and ACE Inhibitors: The Truth Beyond Placebo. Issue 3 (22nd February 2018)

• Record Type: Journal Article
• Authors: Borghi, Claudio; Veronesi, Maddalena
• Is Part Of: Clinical pharmacology & therapeutics. Volume 105:Issue 3(2019)
• Page Start: 550
• Page End: 552
• Publication Date: 2018-02-22
• Subjects: Pharmacology -- Periodicals; Therapeutics -- Periodicals; 615.5
• DOI: 10.1002/cpt.1040
• Languages: English
• ISSNs: 0009-9236

Abstract

Abstract : Angiotensin converting enzyme (ACE) inhibitors are extensively used for the prevention and treatment of cardiovascular diseases with a wide range of clinical recommendations. The use of ACE inhibitors can cause the onset of a dry cough, whose prevalence has probably been overestimated because of the lack of adequate control. A correct interpretation of available data requires a careful evaluation of placebo‐controlled studies to definitely assess the rate of the most frequent adverse event of ACE inhibition.